価格表

在庫・価格 : 2024年05月08日 12時44分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
ProANP(1-98), EIA Kit (12×8tests)
データシート
BI-20892 BMCバイオメディカ
BIOMEDICA Medizinprodukte GmbH
1 kit ¥167,000
(未発注)
追加

在庫・価格 : 2024年05月08日 12時44分 現在

ProANP(1-98), EIA Kit (12×8tests)

  • 商品コード:BI-20892
  • メーカー:BMC
  • 包装:1kit
  • 価格: ¥167,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Crivellente F et al. Atrial natriuretic peptides in Han Wistar, Sprague-Dawley and spontaneously hypertensive rats. J Appl Toxicol 2012 Jul;32(7):521-6
Crivellente F et al
2012/01/01
PubMed
2 Straub RH et al. Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload. Clin. Rheumatol. 2016 Apr;
Straub RH et al
2016/01/01
PubMed
3 Chachaj A et al. Role of the Lymphatic System in the Pathogenesis of Hypertension in Humans. Lymphat Res Biol 2018 04;16(2):140-146
Chachaj A et al
2018/01/01
PubMed
4 Zelniker T et al. Novel biomarkers for risk stratification in pulmonary arterial hypertension. ERJ Open Res 2015 Oct;1(2)
Zelniker T et al
2015/01/01
PubMed
5 Yilmaz MB et al. Atrial natriuretic peptide predicts impaired atrial remodeling and occurrence of late postoperative atrial fibrillation after surgery for symptomatic aortic stenosis. Cardiology 2006;105(4):207-12
Yilmaz MB et al
2006/01/01
PubMed
6 Wu C et al. Novel MicroRNA Regulators of Atrial Natriuretic Peptide Production. Mol. Cell. Biol. 2016 07;36(14):1977-87
Wu C et al
2016/01/01
PubMed
7 Tomaszewski M et al. Renal Mechanisms of Association between Fibroblast Growth Factor 1 and Blood Pressure. J. Am. Soc. Nephrol. 2015 Dec;26(12):3151-60
Tomaszewski M et al
2015/01/01
PubMed
8 Toma I et al. Intrapericardial angiotensin II stimulates endothelin-1 and atrial natriuretic peptide formation of the in situ dog heart. Exp. Biol. Med. (Maywood) 2006 Jun;231(6):847-51
Toma I et al
2006/01/01
PubMed
9 Tokarik M et al. Natriuretic peptide proANP (1-98), a biomarker of ALI/ARDS in burns. Burns 2013 Mar;39(2):243-8
Tokarik M et al
2013/01/01
PubMed
10 Suresh Babu S et al. Mechanism of stretch-induced activation of the mechanotransducer zyxin in vascular cells. Sci Signal 2012 Dec;5(254):ra91
Suresh Babu S et al
2012/01/01
PubMed
11 Staudt A et al. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Ther Apher Dial 2006 Feb;10(1):42-8
Staudt A et al
2006/01/01
PubMed
12 Stanciu AE et al. Effects of thyroid hormone withdrawal on natriuretic peptides during radioactive iodine therapy in female patients with differentiated thyroid cancer. Scand. J. Clin. Lab. Invest. 2016 Dec;76(8):626-631
Stanciu AE et al
2016/01/01
PubMed
13 Seegers J et al. Natriuretic peptides for the detection of paroxysmal atrial fibrillation. Open Heart 2015;2(1):e000182
Seegers J et al
2015/01/01
PubMed
14 Schwarz K et al. Apoptosis at a distance: remote activation of caspase-3 occurs early after myocardial infarction. Mol. Cell. Biochem. 2006 Jan;281(1-2):45-54
Schwarz K et al
2006/01/01
PubMed
15 Rubattu S et al. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J. Am. Coll. Cardiol. 2006 Aug;48(3):499-505
Rubattu S et al
2006/01/01
PubMed
16 Rosolova H et al. Short to long term mortality of patients hospitalised with heart failure in the Czech Republic--a report from the EuroHeart Failure Survey. Eur. J. Heart Fail. 2005 Aug;7(5):780-3
Rosolova H et al
2005/01/01
PubMed
17 Retterstol L et al. Plasma N-terminal pro-atrial natriuretic peptide predicts death after premature myocardial infarction, but not as well as radionuclide ejection fraction. A ten-year follow-up study. Scand. Cardiovasc. J. 2001 Dec;35(6):373-8
Retterstol L et al
2001/01/01
PubMed
18 Patrianakos AP et al. Restrictive filling pattern is associated with increased humoral activation and impaired exercise capacity in dilated cardiomyopathy. Eur. J. Heart Fail. 2004 Oct;6(6):735-43
Patrianakos AP et al
2004/01/01
PubMed
19 Paniagua R et al. Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial. Clin J Am Soc Nephrol 2008 Mar;3(2):407-15
Paniagua R et al
2008/01/01
PubMed
20 Onal EE et al. Serum atrial natriuretic peptide levels in infants with transient tachypnea of the newborn. J. Matern. Fetal. Neonatal. Med. 2005 Feb;17(2):145-9
Onal EE et al
2005/01/01
PubMed
21 Niebroj-Dobosz I et al. Cardiovascular risk markers in dilated cardiomyopathy in Emery-Dreifuss muscular dystrophy (EDMD). Int. J. Cardiol. 2014 May;173(2):324-5
Niebroj-Dobosz I et al
2014/01/01
PubMed
22 Niccoli G et al. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation. Cardiovasc Revasc Med ;17(3):162-8
Niccoli G et al
PubMed
23 Missbichler A et al. Sandwich ELISA for proANP 1-98 facilitates investigation of left ventricular dysfunction. Eur. J. Med. Res. 2001 Mar;6(3):105-11
Missbichler A et al
2001/01/01
PubMed
24 Meluzin J et al. Noninvasive prediction of the exercise-induced elevation in left ventricular filling pressure in post-heart transplant patients with normal left ventricular ejection fraction. Exp Clin Cardiol 2013;18(2):63-72
Meluzin J et al
2013/01/01
PubMed
25 Lehmann LH et al. Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling. Proc. Natl. Acad. Sci. U.S.A. 2014 Sep;111(37):13499-504
Lehmann LH et al
2014/01/01
PubMed
26 Kim K et al. Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories. Toxicol Pathol 2016 12;44(8):1072-1083
Kim K et al
2016/01/01
PubMed
27 Kemter E et al. Mutation of the Na(+)-K(+)-2Cl(-) cotransporter NKCC2 in mice is associated with severe polyuria and a urea-selective concentrating defect without hyperreninemia. Am. J. Physiol. Renal Physiol. 2010 Jun;298(6):F1405-15
Kemter E et al
2010/01/01
PubMed
28 Jarai R et al. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide. Eur. Heart J. 2005 Feb;26(3):250-6
Jarai R et al
2005/01/01
PubMed
29 H端lsmann M et al. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic pe
H端lsmann M et al
2005/01/01
PubMed
30 H端lsmann M et al. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Eur. Heart J. 2002 Jun;23(11):886-91
H端lsmann M et al
2002/01/01
PubMed
31 Hammerer-Lercher A et al. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers. Clin. Chem. 2004 Jul;50(7):1174-83
Hammerer-Lercher A et al
2004/01/01
PubMed
32 Hammerer-Lercher A et al. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin. Chim. Acta 2001 Aug;310(2):193-7
Hammerer-Lercher A et al
2001/01/01
PubMed
33 Gwechenberger M et al. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers. Eur. J. Clin. Invest. 2004 Dec;34(12):811-7
Gwechenberger M et al
2004/01/01
PubMed
34 Goette A et al. Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide? Circulation 2003 Nov;108(20):2446-9
Goette A et al
2003/01/01
PubMed
35 Galasko G et al. Comparison of the clinical utility of atrial and B type natriuretic peptide measurement for the diagnosis of systolic dysfunction in a low-risk population. J. Clin. Pathol. 2007 May;60(5):570-2
Galasko G et al
2007/01/01
PubMed
36 Franz M et al. Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases. Kidney Int. 2001 May;59(5):1928-34
Franz M et al
2001/01/01
PubMed
37 Engle SK et al. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging. Toxicol. Sci. 2010 Apr;114(2):183-92
Engle SK et al
2010/01/01
PubMed
38 Dunn ME et al. Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy. Toxicol Pathol 2017 02;45(2):344-352
Dunn ME et al
2017/01/01
PubMed
39 Colton HM et al. An initial characterization of N-terminal-proatrial natriuretic peptide in serum of Sprague Dawley rats. Toxicol. Sci. 2011 Apr;120(2):262-8
Colton HM et al
2011/01/01
PubMed
40 Brueckmann M et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005 Jul;112(4):527-34
Brueckmann M et al
2005/01/01
PubMed
41 Berger R et al. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure. Eur. J. Clin. Invest. 2005 Jan;35(1):24-31
Berger R et al
2005/01/01
PubMed
42 Baumane K et al. Association of NT-proANP Level in Plasma and Humor Aqueous with Primary Open-Angle Glaucoma. Curr. Eye Res. 2017 02;42(2):233-236
Baumane K et al
2017/01/01
PubMed
43 Barbato E et al. NT-proANP circulating level is a prognostic marker in stable ischemic heart disease. Int. J. Cardiol. 2012 Mar;155(2):311-2
Barbato E et al
2012/01/01
PubMed
44 Bacaksiz A et al. Assessment of the left atrial volume index and plasma NT-proANP level in patients with acute ST-elevation myocardial infarction. Clinics (Sao Paulo) 2013 Jul;68(7):997-1003
Bacaksiz A et al
2013/01/01
PubMed
45 Assmus B et al. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry
Assmus B et al
2007/01/01
PubMed
46 Bergler-Klein J et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004 May;109(19):2302-8
Bergler-Klein J et al
2004/01/01
PubMed
47 Sharma V et al. Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat. Am. J. Physiol. Heart Circ. Physiol. 2008 Apr;294(4):H1609-20
Sharma V et al
2008/01/01
PubMed
48 H端lsmann M et al. Muscle strength as a predictor of long-term survival in severe congestive heart failure. Eur. J. Heart Fail. 2004 Jan;6(1):101-7
H端lsmann M et al
2004/01/01
PubMed
49 Mazul-Sunko B et al. Proatrial natriuretic peptide (1-98), but not cystatin C, is predictive for occurrence of acute renal insufficiency in critically ill septic patients. Nephron Clin Pract 2004;97(3):c103-7
Mazul-Sunko B et al
2004/01/01
PubMed
50 Niessner A et al. Increases in plasma levels of atrial and brain natriuretic peptides after running a marathon: are their effects partly counterbalanced by adrenocortical steroids? Eur. J. Endocrinol. 2003 Dec;149(6):555-9
Niessner A et al
2003/01/01
PubMed
51 Arora P et al. Weight loss, saline loading, and the natriuretic peptide system. J Am Heart Assoc 2015 Jan;4(1):e001265
Arora P et al
2015/01/01
PubMed
52 Windt WA et al. Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention. J. Am. Soc. Nephrol. 2006 Nov;17(11):3059-66
Windt WA et al
2006/01/01
PubMed
53 Stahrenberg R et al. High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia. J. Neurol. Neurosurg. Psychiatry 2013 May;84(5):479-87
Stahrenberg R et al
2013/01/01
PubMed
54 Mir TS et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 2003 Oct;112(4):896-9
Mir TS et al
2003/01/01
PubMed
55 Kim SK et al. Serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. Korean Circ J 2010 Apr;40(4):185-90
Kim SK et al
2010/01/01
PubMed
56 M淡ller S et al. Reduced baroreflex sensitivity and pulmonary dysfunction in alcoholic cirrhosis: effect of hyperoxia. Am. J. Physiol. Gastrointest. Liver Physiol. 2010 Sep;299(3):G784-90
M淡ller S et al
2010/01/01
PubMed
57 Stanek B et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J. Am. Coll. Cardiol. 2001 Aug;38(2):436-42
Stanek B et al
2001/01/01
PubMed
58 Berger R et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002 May;105(20):2392-7
Berger R et al
2002/01/01
PubMed
59 Hoffmann U et al. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin. Lab. 2005;51(7-8):373-9
Hoffmann U et al
2005/01/01
PubMed
60 Govindan M et al. Prognostic value of left atrial expansion index and exercise-induced change in atrial natriuretic peptide as long-term predictors of atrial fibrillation recurrence. Europace 2012 Sep;14(9):1302-10
Govindan M et al
2012/01/01
PubMed
61 Ellinor PT et al. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J. Am. Coll. Cardiol. 2005 Jan;45(1):82-6
Ellinor PT et al
2005/01/01
PubMed
62 Molhoek SG et al. Atrial and brain natriuretic peptides as markers of response to resynchronisation therapy. Heart 2004 Jan;90(1):97-8
Molhoek SG et al
2004/01/01
PubMed
63 Sin DD et al. Effects of nocturnal noninvasive mechanical ventilation on heart rate variability of patients with advanced COPD. Chest 2007 Jan;131(1):156-63
Sin DD et al
2007/01/01
PubMed
64 Linz W et al. Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats. J Renin Angiotensin Aldosterone Syst 2006 Sep;7(3):155-61
Linz W et al
2006/01/01
PubMed
65 Jain D et al. Neurohumoral activation in percutaneous coronary interventions: apropos of ten vasoactive substances during and immediately following coronary rotastenting. Indian Heart J ;53(3):301-7
Jain D et al
PubMed
66 Amann K et al. Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage. J. Am. Soc. Nephrol. 2001 Dec;12(12):2572-84
Amann K et al
2001/01/01
PubMed
67 Clerico A et al. Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin. Chem. 2000 Oct;46(10):1529-34
Clerico A et al
2000/01/01
PubMed
68 Clerico A et al. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J. Endocrinol. Invest. 2001 Jan;24(1):24-30
Clerico A et al
2001/01/01
PubMed
69 Ellinor PT et al. Reduced apelin levels in lone atrial fibrillation. Eur. Heart J. 2006 Jan;27(2):222-6
Ellinor PT et al
2006/01/01
PubMed
70 Du W et al. Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production. Theranostics 2018;8(15):4155-4169
Du W et al
2018/01/01
PubMed
71 Wakula P et al. CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation. Europace 2017 Apr;19(4):544-551
Wakula P et al
2017/01/01
PubMed
72 Rubattu S et al. Effects of dual angiotensin type 1 receptor/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat. J. Hypertens. 2018 09;36(9):1902-1914
Rubattu S et al
2018/01/01
PubMed
73 Grieshaber P et al. Influence of Left Atrial Appendage Amputation on Natriuretic Peptides-A Randomized Controlled Trial. Thorac Cardiovasc Surg 2019 Mar;
Grieshaber P et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    Crivellente F et al. Atrial natriuretic peptides in Han Wistar, Sprague-Dawley and spontaneously hypertensive rats. J Appl Toxicol 2012 Jul;32(7):521-6
    Crivellente F et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Straub RH et al. Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload. Clin. Rheumatol. 2016 Apr;
    Straub RH et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Chachaj A et al. Role of the Lymphatic System in the Pathogenesis of Hypertension in Humans. Lymphat Res Biol 2018 04;16(2):140-146
    Chachaj A et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Zelniker T et al. Novel biomarkers for risk stratification in pulmonary arterial hypertension. ERJ Open Res 2015 Oct;1(2)
    Zelniker T et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Yilmaz MB et al. Atrial natriuretic peptide predicts impaired atrial remodeling and occurrence of late postoperative atrial fibrillation after surgery for symptomatic aortic stenosis. Cardiology 2006;105(4):207-12
    Yilmaz MB et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Wu C et al. Novel MicroRNA Regulators of Atrial Natriuretic Peptide Production. Mol. Cell. Biol. 2016 07;36(14):1977-87
    Wu C et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Tomaszewski M et al. Renal Mechanisms of Association between Fibroblast Growth Factor 1 and Blood Pressure. J. Am. Soc. Nephrol. 2015 Dec;26(12):3151-60
    Tomaszewski M et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Toma I et al. Intrapericardial angiotensin II stimulates endothelin-1 and atrial natriuretic peptide formation of the in situ dog heart. Exp. Biol. Med. (Maywood) 2006 Jun;231(6):847-51
    Toma I et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Tokarik M et al. Natriuretic peptide proANP (1-98), a biomarker of ALI/ARDS in burns. Burns 2013 Mar;39(2):243-8
    Tokarik M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Suresh Babu S et al. Mechanism of stretch-induced activation of the mechanotransducer zyxin in vascular cells. Sci Signal 2012 Dec;5(254):ra91
    Suresh Babu S et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Staudt A et al. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Ther Apher Dial 2006 Feb;10(1):42-8
    Staudt A et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Stanciu AE et al. Effects of thyroid hormone withdrawal on natriuretic peptides during radioactive iodine therapy in female patients with differentiated thyroid cancer. Scand. J. Clin. Lab. Invest. 2016 Dec;76(8):626-631
    Stanciu AE et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Seegers J et al. Natriuretic peptides for the detection of paroxysmal atrial fibrillation. Open Heart 2015;2(1):e000182
    Seegers J et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Schwarz K et al. Apoptosis at a distance: remote activation of caspase-3 occurs early after myocardial infarction. Mol. Cell. Biochem. 2006 Jan;281(1-2):45-54
    Schwarz K et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Rubattu S et al. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J. Am. Coll. Cardiol. 2006 Aug;48(3):499-505
    Rubattu S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Rosolova H et al. Short to long term mortality of patients hospitalised with heart failure in the Czech Republic--a report from the EuroHeart Failure Survey. Eur. J. Heart Fail. 2005 Aug;7(5):780-3
    Rosolova H et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Retterstol L et al. Plasma N-terminal pro-atrial natriuretic peptide predicts death after premature myocardial infarction, but not as well as radionuclide ejection fraction. A ten-year follow-up study. Scand. Cardiovasc. J. 2001 Dec;35(6):373-8
    Retterstol L et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Patrianakos AP et al. Restrictive filling pattern is associated with increased humoral activation and impaired exercise capacity in dilated cardiomyopathy. Eur. J. Heart Fail. 2004 Oct;6(6):735-43
    Patrianakos AP et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Paniagua R et al. Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial. Clin J Am Soc Nephrol 2008 Mar;3(2):407-15
    Paniagua R et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Onal EE et al. Serum atrial natriuretic peptide levels in infants with transient tachypnea of the newborn. J. Matern. Fetal. Neonatal. Med. 2005 Feb;17(2):145-9
    Onal EE et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Niebroj-Dobosz I et al. Cardiovascular risk markers in dilated cardiomyopathy in Emery-Dreifuss muscular dystrophy (EDMD). Int. J. Cardiol. 2014 May;173(2):324-5
    Niebroj-Dobosz I et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Niccoli G et al. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation. Cardiovasc Revasc Med ;17(3):162-8
    Niccoli G et al
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Missbichler A et al. Sandwich ELISA for proANP 1-98 facilitates investigation of left ventricular dysfunction. Eur. J. Med. Res. 2001 Mar;6(3):105-11
    Missbichler A et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Meluzin J et al. Noninvasive prediction of the exercise-induced elevation in left ventricular filling pressure in post-heart transplant patients with normal left ventricular ejection fraction. Exp Clin Cardiol 2013;18(2):63-72
    Meluzin J et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Lehmann LH et al. Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling. Proc. Natl. Acad. Sci. U.S.A. 2014 Sep;111(37):13499-504
    Lehmann LH et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Kim K et al. Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories. Toxicol Pathol 2016 12;44(8):1072-1083
    Kim K et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Kemter E et al. Mutation of the Na(+)-K(+)-2Cl(-) cotransporter NKCC2 in mice is associated with severe polyuria and a urea-selective concentrating defect without hyperreninemia. Am. J. Physiol. Renal Physiol. 2010 Jun;298(6):F1405-15
    Kemter E et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Jarai R et al. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide. Eur. Heart J. 2005 Feb;26(3):250-6
    Jarai R et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    H端lsmann M et al. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic pe
    H端lsmann M et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    H端lsmann M et al. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Eur. Heart J. 2002 Jun;23(11):886-91
    H端lsmann M et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Hammerer-Lercher A et al. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers. Clin. Chem. 2004 Jul;50(7):1174-83
    Hammerer-Lercher A et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Hammerer-Lercher A et al. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin. Chim. Acta 2001 Aug;310(2):193-7
    Hammerer-Lercher A et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Gwechenberger M et al. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers. Eur. J. Clin. Invest. 2004 Dec;34(12):811-7
    Gwechenberger M et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Goette A et al. Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide? Circulation 2003 Nov;108(20):2446-9
    Goette A et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Galasko G et al. Comparison of the clinical utility of atrial and B type natriuretic peptide measurement for the diagnosis of systolic dysfunction in a low-risk population. J. Clin. Pathol. 2007 May;60(5):570-2
    Galasko G et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Franz M et al. Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases. Kidney Int. 2001 May;59(5):1928-34
    Franz M et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Engle SK et al. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging. Toxicol. Sci. 2010 Apr;114(2):183-92
    Engle SK et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Dunn ME et al. Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy. Toxicol Pathol 2017 02;45(2):344-352
    Dunn ME et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Colton HM et al. An initial characterization of N-terminal-proatrial natriuretic peptide in serum of Sprague Dawley rats. Toxicol. Sci. 2011 Apr;120(2):262-8
    Colton HM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Brueckmann M et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005 Jul;112(4):527-34
    Brueckmann M et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Berger R et al. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure. Eur. J. Clin. Invest. 2005 Jan;35(1):24-31
    Berger R et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Baumane K et al. Association of NT-proANP Level in Plasma and Humor Aqueous with Primary Open-Angle Glaucoma. Curr. Eye Res. 2017 02;42(2):233-236
    Baumane K et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Barbato E et al. NT-proANP circulating level is a prognostic marker in stable ischemic heart disease. Int. J. Cardiol. 2012 Mar;155(2):311-2
    Barbato E et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Bacaksiz A et al. Assessment of the left atrial volume index and plasma NT-proANP level in patients with acute ST-elevation myocardial infarction. Clinics (Sao Paulo) 2013 Jul;68(7):997-1003
    Bacaksiz A et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Assmus B et al. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry
    Assmus B et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Bergler-Klein J et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004 May;109(19):2302-8
    Bergler-Klein J et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Sharma V et al. Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat. Am. J. Physiol. Heart Circ. Physiol. 2008 Apr;294(4):H1609-20
    Sharma V et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    H端lsmann M et al. Muscle strength as a predictor of long-term survival in severe congestive heart failure. Eur. J. Heart Fail. 2004 Jan;6(1):101-7
    H端lsmann M et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Mazul-Sunko B et al. Proatrial natriuretic peptide (1-98), but not cystatin C, is predictive for occurrence of acute renal insufficiency in critically ill septic patients. Nephron Clin Pract 2004;97(3):c103-7
    Mazul-Sunko B et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Niessner A et al. Increases in plasma levels of atrial and brain natriuretic peptides after running a marathon: are their effects partly counterbalanced by adrenocortical steroids? Eur. J. Endocrinol. 2003 Dec;149(6):555-9
    Niessner A et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Arora P et al. Weight loss, saline loading, and the natriuretic peptide system. J Am Heart Assoc 2015 Jan;4(1):e001265
    Arora P et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Windt WA et al. Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention. J. Am. Soc. Nephrol. 2006 Nov;17(11):3059-66
    Windt WA et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Stahrenberg R et al. High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia. J. Neurol. Neurosurg. Psychiatry 2013 May;84(5):479-87
    Stahrenberg R et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Mir TS et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 2003 Oct;112(4):896-9
    Mir TS et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Kim SK et al. Serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. Korean Circ J 2010 Apr;40(4):185-90
    Kim SK et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    M淡ller S et al. Reduced baroreflex sensitivity and pulmonary dysfunction in alcoholic cirrhosis: effect of hyperoxia. Am. J. Physiol. Gastrointest. Liver Physiol. 2010 Sep;299(3):G784-90
    M淡ller S et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Stanek B et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J. Am. Coll. Cardiol. 2001 Aug;38(2):436-42
    Stanek B et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Berger R et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002 May;105(20):2392-7
    Berger R et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Hoffmann U et al. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin. Lab. 2005;51(7-8):373-9
    Hoffmann U et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Govindan M et al. Prognostic value of left atrial expansion index and exercise-induced change in atrial natriuretic peptide as long-term predictors of atrial fibrillation recurrence. Europace 2012 Sep;14(9):1302-10
    Govindan M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Ellinor PT et al. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J. Am. Coll. Cardiol. 2005 Jan;45(1):82-6
    Ellinor PT et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Molhoek SG et al. Atrial and brain natriuretic peptides as markers of response to resynchronisation therapy. Heart 2004 Jan;90(1):97-8
    Molhoek SG et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Sin DD et al. Effects of nocturnal noninvasive mechanical ventilation on heart rate variability of patients with advanced COPD. Chest 2007 Jan;131(1):156-63
    Sin DD et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Linz W et al. Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats. J Renin Angiotensin Aldosterone Syst 2006 Sep;7(3):155-61
    Linz W et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Jain D et al. Neurohumoral activation in percutaneous coronary interventions: apropos of ten vasoactive substances during and immediately following coronary rotastenting. Indian Heart J ;53(3):301-7
    Jain D et al
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Amann K et al. Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage. J. Am. Soc. Nephrol. 2001 Dec;12(12):2572-84
    Amann K et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Clerico A et al. Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin. Chem. 2000 Oct;46(10):1529-34
    Clerico A et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Clerico A et al. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J. Endocrinol. Invest. 2001 Jan;24(1):24-30
    Clerico A et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Ellinor PT et al. Reduced apelin levels in lone atrial fibrillation. Eur. Heart J. 2006 Jan;27(2):222-6
    Ellinor PT et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Du W et al. Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production. Theranostics 2018;8(15):4155-4169
    Du W et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Wakula P et al. CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation. Europace 2017 Apr;19(4):544-551
    Wakula P et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Rubattu S et al. Effects of dual angiotensin type 1 receptor/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat. J. Hypertens. 2018 09;36(9):1902-1914
    Rubattu S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Grieshaber P et al. Influence of Left Atrial Appendage Amputation on Natriuretic Peptides-A Randomized Controlled Trial. Thorac Cardiovasc Surg 2019 Mar;
    Grieshaber P et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed